Inventor
MAYANK JOSHI
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
H04LTransmission of digital information, e.g. telegraphic communication29%
PatentTitleYear
12,589,075Osmotic dosage forms comprising deutetrabenazine and methods of use thereof202612,580,911Systems and methods for use in securing digital identities for user authentication202611,974,974Controlled-release tablets, method of making, and method of use thereof202411,695,747Multi-device single sign-on202311,311,488Osmotic dosage forms comprising deutetrabenazine and methods of use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to AUSPEX PHARMACEUTICALS INC (2)· patent assignee history
2022–2026Based in US· patent location history
2023Patents assigned to VMWARE INC (1)· patent assignee history
2023–2026Based in IN· patent location history
2024Patents assigned to ALVOGEN INC (1)· patent assignee history
2026Patents assigned to AUSPEX PHARMACEUTICALS LLC (1)· patent assignee history
2026Patents assigned to MASTERCARD INTERNATIONAL INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AUSPEX PHARMACEUTICALS INC | 2 | 2022–2026 |
| ALVOGEN INC | 1 | 2024 |
| AUSPEX PHARMACEUTICALS LLC | 1 | 2026 |
| MASTERCARD INTERNATIONAL INC | 1 | 2026 |
| VMWARE INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2022–2026 |
| IN | 2 | 2023–2026 |